Cricut
CRCT
6.36
-0.02
-0.31%
Cricut
US · CRCT
#3067 by market cap
Listed 2021
6.36
-0.02
-0.31%
Live - 5344 symbols - heartbeat 443s ago
· 2026-10-08 06:25
Pre-market
6.44
+1.26%
After-hours
6.36
0.00%
- Market cap
- 1.33B
- P/E (TTM)i
- 15.90
- P/Bi
- 3.62
- EPSi
- 0.35
- Div yieldi
- 3.14%
- 52W posi
- 90%
Reader sentiment
Are you bullish or bearish on CRCT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 5.72, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -0.53% YoY
Margins
- Gross margin
- 55.08%
- Operating margin
- 13.55%
- Net margin
- 10.82%
Key ratios & quality
- PEG ratioi
- 1.95
- Altman Z-Scorei
- 5.72
PEG uses trailing P/E against the 3-year net income growth rate (8.13%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 339.79M | 486.55M | 959.03M | 1.31B | 886.30M | 765.15M | 712.54M | 708.78M |
| Gross profit | 111.10M | 142.35M | 332.37M | 457.45M | 349.89M | 343.29M | 352.79M | 390.43M |
| Selling & admin expenses | 49.06M | 62.12M | 92.93M | 185.23M | 193.03M | 208.26M | 216.28M | 227.88M |
| Research & development | 24.06M | 26.67M | 38.93M | 79.81M | 76.91M | 65.05M | 60.40M | 66.52M |
| Operating profit | 37.98M | 53.56M | 200.51M | 192.41M | 79.95M | 69.99M | 76.11M | 96.03M |
| Pretax profit | 36.15M | 50.27M | 199.19M | 192.37M | 81.98M | 79.78M | 88.88M | 107.89M |
| Tax | 8.72M | 11.06M | 44.62M | 51.90M | 21.32M | 26.15M | 26.05M | 31.19M |
| Net profit | 27.43M | 39.21M | 154.58M | 140.47M | 60.67M | 53.64M | 62.83M | 76.71M |
| Basic EPS | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.22 | 0.18 | 0.70 | 0.64 | 0.28 | 0.24 | 0.29 | 0.35 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 162.63M | 172.11M | 170.44M | 203.60M | 159.47M | 156.29M |
| Gross profit | 98.35M | 101.54M | 94.10M | 96.45M | 92.70M | 116.41M |
| Selling & admin expenses | 53.35M | 54.67M | 54.58M | 65.27M | 53.21M | 52.13M |
| Research & development | 15.66M | 16.76M | 16.87M | 17.24M | 16.60M | 16.86M |
| Operating profit | 29.34M | 30.11M | 22.65M | 13.94M | 22.89M | 47.42M |
| Pretax profit | 32.62M | 33.84M | 25.63M | 15.80M | 25.09M | 50.31M |
| Tax | 8.71M | 9.36M | 5.12M | 8.01M | 4.77M | 11.26M |
| Net profit | 23.91M | 24.49M | 20.51M | 7.79M | 20.32M | 39.05M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.11 | 0.11 | 0.10 | 0.04 | 0.10 | 0.19 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 218.88M | 287.19M | 538.81M | 928.10M | 811.26M | 619.97M | 580.21M | 499.59M |
| Cash & ST investments | 6.02M | 6.65M | 122.22M | 241.60M | 299.20M | 245.14M | 336.91M | 275.65M |
| Inventory | 145.15M | 213.19M | 248.75M | 454.17M | 351.68M | 244.47M | 115.26M | 102.66M |
| Total assets | 241.62M | 317.65M | 581.40M | 1.01B | 949.63M | 750.12M | 693.04M | 580.81M |
| Total current liabilities | 146.09M | 175.58M | 346.50M | 308.37M | 254.06M | 196.46M | 203.37M | 221.08M |
| Short-term debt | 33.14M | 37.57M | -- | 3.76M | 5.44M | 5.23M | 3.90M | 3.61M |
| Long-term debt | 11.67M | 17.84M | -- | -- | -- | -- | -- | -- |
| Total liabilities | 161,852,000.00 | 196,503,000.00 | 352,475,000.00 | 332,274,000.00 | 276,892,000.00 | 215,249,000.00 | 226,274,000.00 | 237,245,000.00 |
| Total equity | 79.77M | 121.14M | 228.93M | 673.98M | 672.74M | 534.87M | 466.76M | 343.56M |
| Retained earnings | -377.82M | -338.61M | -184.03M | -43.56M | 0 | 28.51M | 0 | 3.96M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 561.23M | 599.19M | 441.10M | 499.59M | 461.93M | 500.00M |
| Cash & ST investments | 356.67M | 376.94M | 207.10M | 275.65M | 255.67M | 286.27M |
| Inventory | 114.40M | 124.80M | 134.90M | 102.66M | 106.04M | 105.84M |
| Total assets | 681.65M | 721.51M | 564.25M | 580.81M | 543.76M | 585.68M |
| Total current liabilities | 170.97M | 393.10M | 187.04M | 221.08M | 169.86M | 200.94M |
| Short-term debt | 3.82M | 3.61M | 3.61M | 3.61M | 3.58M | 3.17M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 191,480,000.00 | 412,574,000.00 | 205,862,000.00 | 237,245,000.00 | 186,273,000.00 | 217,493,000.00 |
| Total equity | 490.17M | 308.94M | 358.39M | 343.56M | 357.49M | 368.19M |
| Retained earnings | 26.00M | 0 | 20.51M | 3.96M | 27.48M | 42.23M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -8.30M | 3.86M | 248.23M | -104.95M | 117.68M | 288.10M | 264.97M | 200.23M |
| Depreciation & amortization | 8.06M | 9.18M | 14.12M | 19.39M | 26.96M | 30.04M | 29.01M | 24.44M |
| Free cash flow | -16.42M | -10.23M | 226.39M | -140.74M | 83.91M | 264.38M | 246.63M | 175.81M |
| Dividends paid | 0 | 0 | -51.20M | 0 | 0 | -294.13M | -109.97M | -202.10M |
| Stock buybacks / issuance | -297.00K | -728.00K | -3.04M | 262.01M | -18.58M | -20.33M | -38.49M | -24.75M |
| Ending cash balance | 6.02M | 6.65M | 122.22M | 241.60M | 224.94M | 142.19M | 232.14M | 256.22M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 61.17M | 36.16M | 20.48M | 82.43M | 26.85M | 50.35M |
| Depreciation & amortization | 6.11M | 5.98M | 6.05M | 6.30M | 5.61M | 6.14M |
| Free cash flow | 56.27M | 30.46M | 13.89M | 75.20M | 17.72M | 40.85M |
| Dividends paid | -21.49M | 0 | -180.58M | -29.00K | -21.16M | 0 |
| Stock buybacks / issuance | -12.00M | -4.74M | -2.35M | -5.65M | -12.26M | -7.52M |
| Ending cash balance | 252.14M | 298.06M | 187.87M | 256.22M | 236.50M | 266.91M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 61.85 | 39.03 | 88.31 | 31.12 | 9.01 | 8.88 | 12.55 | 18.93 |
| ROA %i | 20.42 | 14.02 | 34.39 | 17.70 | 6.20 | 6.31 | 8.71 | 12.04 |
| ROIC %i | 39.61 | 26.04 | 88.31 | 29.83 | 8.76 | 7.81 | 10.72 | 16.49 |
| 5-year avg ROE %i | -- | -- | -- | -- | 45.87 | 35.27 | 29.97 | 16.10 |
| EBIT margin %i | 11.18 | 11.01 | 20.91 | 14.73 | 9.02 | 10.47 | 12.52 | 15.30 |
| FCF / sales %i | -- | -- | 23.61 | -- | 9.47 | 34.55 | 34.61 | 24.81 |
| Current ratioi | 1.50 | 1.64 | 1.55 | 3.01 | 3.19 | 3.16 | 2.85 | 2.26 |
| Quick ratioi | 0.46 | 0.41 | 0.82 | 1.43 | 1.72 | 1.81 | 2.16 | 1.66 |
| Debt / assetsi | 18.54 | 17.45 | 0.00 | 1.94 | 2.04 | 1.89 | 2.19 | 2.00 |
| LT debt / equityi | 14.63 | 14.73 | -- | 2.34 | 2.07 | 1.67 | 2.42 | 2.33 |
| Interest coveragei | -- | -- | -- | -- | -- | 248.01 | 273.63 | 191.29 |
| Revenue CAGR (3Y) %i | -- | -- | -- | 56.65 | 22.13 | -7.25 | -18.29 | -7.18 |
| Net income CAGR (3Y) %i | -- | -- | -- | 72.36 | 15.66 | -29.73 | -23.52 | 8.13 |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | 5.31 | -- | 27.96 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 12.87 | 18.96 | 19.38 | 18.93 | 17.25 | 25.90 |
| ROA %i | 9.55 | 9.81 | 13.17 | 12.04 | 11.93 | 13.41 |
| ROIC %i | 10.98 | 16.06 | 16.84 | 16.49 | 15.13 | 23.07 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 13.21 | 13.71 | 15.28 | 15.30 | 14.30 | 17.02 |
| FCF / sales %i | 35.51 | 35.35 | 27.96 | 24.81 | 19.45 | 21.41 |
| Current ratioi | 3.28 | 1.52 | 2.36 | 2.26 | 2.72 | 2.49 |
| Quick ratioi | 2.51 | 1.17 | 1.58 | 1.66 | 1.90 | 1.78 |
| Debt / assetsi | 2.13 | 1.86 | 2.22 | 2.00 | 1.97 | 1.77 |
| LT debt / equityi | 2.18 | 3.17 | 2.49 | 2.33 | 1.99 | 1.96 |
| Interest coveragei | 288.68 | 300.26 | 257.43 | 191.29 | 177.68 | 207.05 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Platform is the largest reported line at 54.39% of revenue, across 2 reported segments.
- Products follows at 45.61%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Platform54.39%
Products45.61%
Quote time 2026-10-08 06:25:39 · For reference only, not investment advice and not tailored to your situation.